Skip to main content
Year archive

Immunovia — 2020 filings

All 61 regulatory filings released by Immunovia (IMMNOV) in 2020, sourced directly from the official regulator.

61 Filings
2020 Period
2020 filings (61)
Filing Released Lang
Major Shareholding Notification 2020
Major Shareholding Notification
2020-12-03 English
Invitation to telephone conference in response to Dagens Industri’s article published on December 1
Report Publication Announcement
2020-12-02 English
Inbjudan till telefonkonferens med anledning av artikel i Dagens Industri den 1 december
Regulatory Filings
2020-12-02 Swedish
Verkställande Direktör Patrik Dahlen köper Immunovia-aktier
Director's Dealing
2020-11-17 Swedish
Chief Executive Officer, Patrik Dahlen Buys Immunovia Shares
Director's Dealing
2020-11-17 English
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-12 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-12 English
Immunovia presenterar kompletterande information om IMMray® PanCan-d Verifieringsstudien
Regulatory Filings
2020-11-02 Swedish
Immunovia Provides Complementary Details on the IMMray[™] PanCan-d Verification Study
Regulatory Filings
2020-11-02 English
Förändring av antal aktier och röster i Immunovia AB (publ)
Share Issue/Capital Change
2020-10-30 Swedish
Change in the Number of Shares and Votes in Immunovia AB (publ)
Share Issue/Capital Change
2020-10-30 English
Immunovia Announces Completion of Analysis from the IMMray[™] PanCan-d Verification Study
Earnings Release Q4 2020
2020-10-26 English
Immunovia meddelar att analysen av verifieringsstudien för IMMray [® ]PanCan-d har slutförts
Earnings Release Q4 2020
2020-10-26 Swedish
Immunovia meddelar positiva resultat från verifieringsstudien för IMMray[®] PanCan-d
Regulatory Filings
2020-09-29 Swedish
Immunovia Announces Positive Results from the IMMray[™] PanCan-d Verification Study
Regulatory Filings
2020-09-29 English
Immunovia Announces Management Team Changes
Board/Management Information
2020-09-02 English
Immunovia meddelar förändringar i ledningsgruppen
Board/Management Information
2020-09-02 Swedish
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IMMUNOVIA AB
AGM Information
2020-08-31 Swedish
NOTICE OF EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB
AGM Information
2020-08-31 English
Immunovia annonserar VD succession: Utser Patrik Dahlen till ny VD
Board/Management Information
2020-08-26 Swedish
Immunovia Announces CEO Transition: Appoints Patrik Dahlen as New CEO
Board/Management Information
2020-08-26 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-20 Swedish
Immunovia Reports Second Quarter Interim Report January – June 2020
Interim / Quarterly Report H1 2020
2020-08-20 English
Immunovia rapporterar delårsrapport för andra kvartalet januari - juni 202
Interim / Quarterly Report H1 2020
2020-08-20 Swedish
Change in the number of shares and votes in Immunovia AB (publ)
Share Issue/Capital Change
2020-06-30 English
Förändring av antal aktier och röster i Immunovia AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2020-06-30 Swedish
Immunovia Targeting Long-Term Market Penetration of 30% for IMMray™ PanCan-d
Regulatory Filings
2020-06-30 English
Immunovia sätter mål för långsiktig marknadspenetration på 30 procent för IMMray® PanCan-d
Regulatory Filings
2020-06-30 Swedish
Immunovia utökar sitt lungcancerprogram baserat på l ovande resultat från den aktuella forskningsstudien
Regulatory Filings
2020-06-26 Swedish
Immunovia Expands its Lung Cancer Program Based on Encouraging Results from the Current Discovery Study
Regulatory Filings
2020-06-26 English
Immunovia raised ~ 400m SEK to Further Accelerate the Market Introduction of the First Test for Early Detection of Pancreatic Cancer, the IMMray[™] PanCan-d
Capital/Financing Update
2020-06-09 English
Immunovia tillfördes cirka 400 MSEK för att ytterligare påskynda marknadsintroduktionen av det första testet för tidig upptäckt av bukspottkörtelcancer, IMMray[®] PanCan-d
Capital/Financing Update
2020-06-09 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-06-05 English
Immunovia has completed a directed share issue and thereby raises approximately MSEK 400
Share Issue/Capital Change
2020-06-04 English
Immunovia har genomfört en riktad nyemission av aktier och tillförs härigenom cirka 400 MSEK
Share Issue/Capital Change
2020-06-04 Swedish
Immunovia Intends To Carry Out A Directed Share Issue Through An Accelerated Book Building Process
Capital/Financing Update
2020-06-03 English
Immunovia offentliggör avsikt att genomföra en riktad nyemission av aktier genom ett accelererat bookbuilding-förfarande
Capital/Financing Update
2020-06-03 Swedish
Immunovia Provides Forth Update During COVID-19 Pandemic
Earnings Release FY 2020
2020-05-27 English
Immunovia lämnar en fjärde uppdatering under covid-19-pandemin
Regulatory Filings
2020-05-27 Swedish
Immunovia lämnar en tredje uppdatering under covid-19-pandemin
Earnings Release Q4 2020
2020-05-13 Swedish
Immunovia Provides Third Update During COVID-19 Pandemic
Call Transcript
2020-05-13 English
Immunovia - Report from AGM
AGM Information
2020-05-08 English
Immunovia Stämmokommuniké
AGM Information
2020-05-08 Swedish
Immunovia Reports First Quarter Interim Report January – March 2020
Interim / Quarterly Report Q1 2020
2020-04-28 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-28 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-28 English
Immunovia rapporterar delårsrapport för första kvartalet januari - mars 2020
Interim / Quarterly Report Q1 2020
2020-04-28 Swedish
Immunovia and Global Pharmaceutical Company Agree on Early Termination of Lung Cancer Collaboration
Regulatory Filings
2020-04-08 English
Immunovia och globalt läkemedelsbolag överens om förtida avslut på lungcancersamarbete
Regulatory Filings
2020-04-08 Swedish
Kallelse till Årsstämma i Immunovia AB
AGM Information
2020-04-03 Swedish
Kallelse till Årsstämma i Immunovia AB
AGM Information
2020-04-03 English
Immunovia Takes Action During COVID-19 Pandemic and Remains Focused on Launch of IMMray[™] PanCan-d
Environmental & Social Information
2020-04-01 English
Immunovia vidtar åtgärder under COVID-19-pandemin och behåller fokus på lanseringen av IMMray® PanCan-d
Regulatory Filings
2020-04-01 Swedish
Audit Report / Information 2019
Audit Report / Information FY 2019
2020-04-01 Swedish
Annual Report 2019
Annual Report FY 2019
2020-04-01 English
Styrelseledamot Hans Johansson köper Immunovia aktier
Director's Dealing
2020-03-26 Swedish
Board Member Hans Johansson Buys Immunovia Shares
Director's Dealing
2020-03-26 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q4 2019
2020-02-14 Swedish
Annual Report 2019
Annual Report FY 2019
2020-02-14 English
Immunovia Strengthen Management with New Senior VP of Sales North America Ahead of the IMMray™ PanCan-d Test Launch
Board/Management Information
2020-01-13 English
Immunovia förstärker management med ny Senior VP Sales North America inför lanseringen av IMMray ® PanCan-d
Board/Management Information
2020-01-13 Swedish